Diabetes mellitus test

Test flow journey

What is diabetes?

What is “Spot” test (i.e. blood glucose & HbA1c)?

Blood glucose test: measures the glucose, i.e. a type of sugar, in the blood. Too much or too little glucose in the blood can be a sign of a serious medical condition1.
HbA1c test: measures the amount of glucose attached to the hemoglobin, a protein in the red blood cells. Everybody has some sugar attached to their hemoglobin, but people with higher blood sugar levels have more.

Individual having one or more risk factors is recommended to take the HbA1c test every 3 years
Prediabetes patient is recommended to take the HbA1c test every 1 to 2 years
Diabetes patient is recommended to get a HbA1c test at least twice a year²

Blood glucose level and HbA1c value is indicative of the diabetes status.

Ref:

Diabetes Tests. Centers for Disease Control and Prevention. Link: https://www.cdc.gov/diabetes/basics/getting-tested.html. Accessed 01-Aug-2022.
All About Your A1c. Centers for Disease Control and Prevention. Link: https://www.cdc.gov/diabetes/managing/managing-blood-sugar/a1c.html. Accessed 01-Aug-2022.

What is Diabetes Mellitus Complication Assessment (DMCA)?

a series of checking to assess the risk of diabetes related complications
the ultimate goal of treating / managing diabetes is to prevent the complications led by diabetes
a constantly high level of blood glucose may result in macrovascular and microvascular complications, and disrupt the nervous system. Multiple organs could be affected and the following acute and chronic complications may occur:

Acute complications:

Hyperglycemia diabetic coma
Hypoglycemic diabetic coma

Chronic complications:

cardiovascular disease (heart disease, stroke)
microvascular and nerve disease (leading to kidney failure, or commonly called diabetic kidney disease)
retinopathy (commonly called diabetic eye disease), cataract and glaucoma, causing blindness
poor blood flow in feet and neuropathy; infection, ulcer, or gangrene may cause amputation (commonly called diabetic foot)

Diabetes patients are recommended to take the complication assessment every 1 to 2 years.
Advance booking is required for the complication assessment. The whole procedure is conducted by healthcare professional and it takes 1-2 hours to complete.

Ref:

Prevent Diabetes Complications. Hong Kong Diabetes Specialist Centre. Link: https://hkdmcentre.com/en/hong-kong-diabetes-specialist-centre/. Accessed 01-Aug-2022.
American Diabetes Association; 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020. Diabetes Care 1 January 2020; 43 (Supplement_1): S135–S151. https://doi.org/10.2337/dc20-S011

What is NT-proBNP?

NT-proBNP is a protein released by the heart when the heart wall is stretched
NT-proBNP can be used to diagnose heart failure, assess its severity and monitor its progression over time.^1–5
In recent years, NT-proBNP test has been proven to be helpful in assessing the risk of cardiovascular diseases (CVD) for patients with type 2 diabetes mellitus. For those tested to have a value of ≥ 125 pg/mL, the hospitalization & mortality rate due to CVD are 3 times higher than those tested <125 pg/mL⁶.
Compared to traditional biomarkers (i.e. HbA1c & Albuminuria), NT-proBNP demonstrates superiority in predicting short to mid term risk of heart failure and CVD^7,8.
Diabetes patients may consider incorporating NT-proBNP testing in the complication assessment for better risk assessment of CVD and it is recommended to take the test every 1-2 years.
Blood glucose level and HbA1c value is indicative of the diabetes status.

Ref:

Januzzi et al. Eur Heart J. 2006;27:330-7;
Ponikowski et al. Eur Heart J. 2016;37;2129-200;
Yancy et al. JACC. 2017;70:776-97;
Panagopoulou et al. Curr Top Med Chem. 2013;13:82-94;
McKie et al. J Am Coll Cardiol. 2016;68:2437-9.
Huelsmann, M. et al.,Eur Heart J., 2008; Vol. 29, pp. 2259-2264
Neuhold et al. Eur J Clin Invest. 2011;41:1292-98
Clodi et al. Eur J Prev Cardiol. 2012;19:944-51.

Offer for related products and services

What is “Spot” test (i.e. blood glucose & HbA1c)?

Blood Glucose + HbA1c test (Spot test) Discount price: HK$280 Original price: HK:$290

What is Diabetes Mellitus Complication Assessment (DMCA)?

Diabetes Mellitus Complication Assessment (DMCA) Discount price: HK$3,250 Original price: HK$3,300

What is NT-proBNP?

Diabetes Mellitus Complication Assessment (DMCA) + NT-proBNP Discount price: HK$3,900 Original price: HK$3,990

Blood glucose meter set Discount price HK:$625 Original price HK:$688

Notes:
• Offer period last until 18 November 2022. Products and services are available while stock lasts.
• The test and the test results are endorsed by Dr. Francis CC Chow, from the Hong Kong Diabetes Specialist Centre.
• The above items are provided by relevant Merchant. Please refer to the relevant DrGo Health Store webpage for details of each item.
• If there is any inconsistency or ambiguity between the English and Chinese versions, the English version shall prevail.
• eSmartHealth may revise any terms and conditions from time to time without prior notice. In case of dispute, the decision of eSmartHealth shall be final.

Disclaimer: The Merchant is the service provider of the Product / Service. eSmartHealth Limited (“eSmartHealth”, operator of DrGo and DrGo Health Store) is not the service provider of the Product / Service. eSmartHealth is not licensed or registered to provide medical, healthcare, dietitian and exercise advice and services. The relationship between eSmartHealth and the user does not constitute a doctor–patient / healthcare professional–patient / dietitian-client / personal trainer-client relationship, and a doctor–patient / healthcare professional–patient / dietitian-client / personal trainer-client relationship will exist only and exclusively between a medical practitioner / healthcare professional / dietitian / personal trainer and a user. eSmartHealth does not recommend or endorse any merchants or their products or services and are not liable or responsible, and do not endorse or support or recommend any information, advice, opinion, diagnosis, treatment, service, medical certificate and/or medication so prescribed or given by any merchants or any other matters arising from or in relation to the same. eSmartHealth is not the provider and does not endorse the test nor any results. Participants of the test are recommended to seek independent medical advice is necessary.

Personal Information Collection Statement
The personal data and other information that you provided in connection with this test and other information collected, generated and/or compiled by us about you from time to time subsequently (collectively, "Data") will be collected, used and retained by us, eSmartHealth Limited, in accordance with the requirements of the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong) and other applicable laws, rules and regulations. The details of the collection, compilation, retention, use, disclosure and processing of the Data and any further information about the test and its related purposes are set out in the applicable terms and conditions of our “Privacy Statement” (available at DrGo website: www.drgo.com.hk and the DrGo App) and this “Personal Information Collection Statement”. The Data may be disclosed to, used or retained by other members of the HKT Group, their respective agents and business partners for purposes related to the test (including anonymous statistical research) and other purposes to which you have consented at any time. You are entitled to access, correct or enquire about your personal data being held by us. For any such request, please do so by writing to the Privacy Compliance Officer (eSmartHealth Limited, GPO Box 9896 or privacy@pccw.com).